These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 27100028)

  • 1. Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.
    Reddy SK; Parker RJ; Leach JW; Hill MJ; Burgart LJ
    J Surg Oncol; 2016 Mar; 113(4):456-62. PubMed ID: 27100028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the clinical risk score: an analysis of molecular biomarkers in the era of modern chemotherapy for resectable hepatic colorectal cancer metastases.
    Maithel SK; Gönen M; Ito H; Dematteo RP; Allen PJ; Fong Y; Blumgart LH; Jarnagin WR; D'Angelica MI
    Surgery; 2012 Feb; 151(2):162-70. PubMed ID: 21982065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.
    Turan N; Benekli M; Koca D; Ustaalioglu BO; Dane F; Ozdemir N; Ulas A; Oztop I; Gumus M; Ozturk MA; Berk V; Kucukoner M; Uner A; Balakan O; Helvaci K; Ozkan S; Yilmaz U; Buyukberber S;
    Oncology; 2013; 84(1):14-21. PubMed ID: 23076023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
    Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
    Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection and peri-operative chemotherapy for colorectal cancer liver metastases: A population-based study.
    Booth CM; Nanji S; Wei X; Biagi JJ; Krzyzanowska MK; Mackillop WJ
    Eur J Surg Oncol; 2016 Feb; 42(2):281-7. PubMed ID: 26558526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases.
    Simoneau E; Alanazi R; Alshenaifi J; Molla N; Aljiffry M; Medkhali A; Boucher LM; Asselah J; Metrakos P; Hassanain M
    J Surg Oncol; 2016 Mar; 113(4):449-55. PubMed ID: 26955907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy.
    Chang HH; Leeper WR; Chan G; Quan D; Driman DK
    Am J Surg Pathol; 2012 Apr; 36(4):570-6. PubMed ID: 22301494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis.
    Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY
    Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy.
    Parkin E; O'Reilly DA; Adam R; Kaiser GM; Laurent C; Elias D; Capussotti L; Renehan AG;
    Eur J Surg Oncol; 2014 Nov; 40(11):1436-44. PubMed ID: 25189474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.
    Neumann UP; Thelen A; Röcken C; Seehofer D; Bahra M; Riess H; Jonas S; Schmeding M; Pratschke J; Bova R; Neuhaus P
    Surgery; 2009 Jul; 146(1):52-9. PubMed ID: 19541010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases after hepatic resection: which method to use?
    Dede K; Salamon F; Landherr L; Jakab F; Bursics A
    Pathol Oncol Res; 2015 Jan; 21(1):173-9. PubMed ID: 24898285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study on multi-disciplinary team and surgery for resectable colorectal cancer with liver metastases].
    Yao HW; Xiu DR; Fu W; Yuan J; Jiang B; Wang DC; Ma CL; Yuan CH; Sun T; Ma LW; Cao BS; Liu JY; Chen M; Chen W; Tan S; Huang YH; Zhang L; Shi XY
    Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):961-5. PubMed ID: 23302476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
    Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
    Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.
    Hasegawa Y; Nitta H; Sasaki A; Takahara T; Itabashi H; Katagiri H; Otsuka K; Nishizuka S; Wakabayashi G
    Surgery; 2015 Jun; 157(6):1065-72. PubMed ID: 25791030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients.
    Viganò L; Capussotti L; Lapointe R; Barroso E; Hubert C; Giuliante F; Ijzermans JN; Mirza DF; Elias D; Adam R
    Ann Surg Oncol; 2014 Apr; 21(4):1276-86. PubMed ID: 24346766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.
    Okuno M; Hatano E; Seo S; Taura K; Yasuchika K; Nakajima A; Yazawa T; Furuyama H; Kawamoto H; Yagi S; Nishitai R; Fujikawa T; Arimoto A; Zaima M; Yoshimura T; Terajima H; Kaihara S; Manaka D; Tanaka A; Uemoto S
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):881-8. PubMed ID: 25155418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, tolerability, and efficacy of oxaliplatin-based adjuvant chemotherapy after curative resection of hepatic or extrahepatic metastases of Stage IV colorectal cancer.
    Nakayama I; Suenaga M; Wakatsuki T; Ichimura T; Ozaka M; Takahari D; Shinozaki E; Chin K; Ueno M; Mizunuma N; Yamaguchi T
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):133-9. PubMed ID: 25994854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.